The BEST3 trial: is the Cytosponge TFF3 biomarker test oven-ready for primary care?
The Cytosponge test could help diagnosis of Barrett’s oesophagus in people who are on medication for long term heartburn. A… Read More
The Cytosponge test could help diagnosis of Barrett’s oesophagus in people who are on medication for long term heartburn. A… Read More
CanTest researchers have contributed a whopping 3 editorials to the July edition of the British Journal of General Practice! All… Read More
Recommendations for use of the faecal immunochemical test (FIT) for investigating low-risk symptoms of colorectal cancer in primary care vary… Read More
The COVID-19 pandemic is predicted to increase cancer deaths. Here, CanTest researcher Dr Dan Jones considers the effects of the… Read More
Dr Yin Zhou shares insights from her new paper on how imaging activity can possibly signal missed diagnostic opportunities in bladder… Read More
Skin cancer is one of the most common cancers in the world, and the incidence is increasing. CanTest Director Dr… Read More
The science supporting early symptomatic diagnosis of cancer is evolving, this realisation was one of the key drivers supporting the… Read More
Stephen Bradley, a GP and CanTest research fellow at the University of Leeds, recently travelled to Washington DC to learn… Read More